Microbial contamination of medical devices and infection prone areas in hygiene critical environments is one of the main causes of healthcare associated infections. Healthcare associated infection is the 4th leading cause of death after cancer, heart disease and stroke. Besides antibiotic (antibacterial, antifungal, and antiviral therapies), one potential strategy for breaking the chain of transmission of infections is via engineering novel antimicrobial surfaces.

However, existing solution has been limited to the use of disinfectants, QUATs, UV-C, Hydrogen peroxide aerosol, chlorhexidine among others. Regrettably, these antimicrobial solutions are costly, inefficient and ineffective. Contrarily, novel Mechanobactericidal technology is a one-time investment, which imparts antimicrobial property on surfaces of both hygiene critical environment and biomedical implant devices. Coupled with hand washing, the technology provides a one-time bottom-up surface engineering approach to solving the problem of healthcare associated infections and antimicrobial resistance. Novel mechanobactericidal technology provides a high-end, custom antimicrobial surface technology for metallic, ceramic, plastic and textile touch surfaces in hospitals, hygiene critical environment, food, transportation, educational and residential facilities.

Finally, the novel mechanobactericidal technology would presumably provide solution to the Sustainable Development Goal-SDG 8 (Job creation) and Goal 3 (Good health and wellbeing)

World IP Day with Dr. Henry Agbe (https://www.knust.edu.gh/news/news-items/world-ip-day-dr-henry-agbe)